Երկիր: Միացյալ Թագավորություն
Լեզու: անգլերեն
Աղբյուրը: MHRA (Medicines & Healthcare Products Regulatory Agency)
Amiodarone hydrochloride
Sanofi
C01BD01
Amiodarone hydrochloride
50mg/1ml
Solution for injection
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 02030200; GTIN: 5013417102057 5000283655596
PACKAGE LEAFLET: INFORMATION FOR THE USER CORDARONE® X 150MG/3ML, SOLUTION FOR INJECTION amiodarone hydrochloride Is this leaflet hard to see or read? Phone 0845 372 7101 for help READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START HAVING THIS MEDICINE • Keep this leaflet. You may need to read it again • If you have any further questions, ask your doctor, nurse or pharmacist • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours • If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist IN THIS LEAFLET: 1. What Cordarone X is and what it is used for 2. Before you have Cordarone X 3. How Cordarone X is given 4. Possible side effects 5. How to store Cordarone X 6. Further information Cordarone X 150mg/3ml, solution for injection (called Cordarone X in this leaflet) contains a medicine called amiodarone hydrochloride. This belongs to a group of medicines called anti-arrhythmics. It works by controlling the uneven beating of your heart (called ‘arrhythmias’). Having the injection helps your heartbeat to return to normal. Cordarone X is normally only given in a hospital when a quick response is needed or when tablets cannot be given. Cordarone X can be used to: • Treat uneven heartbeats where other medicines either have not worked or cannot be used • Treat an illness called Wolff-Parkinson-White Syndrome. This is where your heart beats unusually fast • Treat other types of fast or uneven heartbeats known as ‘atrial flutter’ or ‘atrial fibrillation'. Cordarone X is used only when other medicines cannot be used • Treat fast heartbeats which may happen suddenly and may be uneven. Cordarone X is used only when other medicines cannot be used 2. BEFORE YOU HAVE CORDARONE X DO NOT HAVE THIS MEDICINE AND TELL YOUR DOCTOR, PHARMACIST OR NURSE IF: × You are allergic (hypersensitive) to: - iodine - amiodarone *701117* SENS DE DEROULEMENT Կարդացեք ամբողջական փաստաթուղթը
OBJECT 1 CORDARONE X INTRAVENOUS Summary of Product Characteristics Updated 31-May-2017 | SANOFI 1. Name of the medicinal product Cordarone X 150mg/3ml Solution for Injection 2. Qualitative and quantitative composition Each 3ml ampoule contains 150mg amiodarone hydrochloride. For excipients, see 6.1 3. Pharmaceutical form Solution for injection. 4. Clinical particulars 4.1 Therapeutic indications Treatment should be initiated and normally monitored only under hospital or specialist supervision. Cordarone X Intravenous is indicated only for the treatment of severe rhythm disorders not responding to other therapies or when other treatments cannot be used. Tachyarrhythmias associated with Wolff-Parkinson-White syndrome. All types of tachyarrhythmias including supraventricular, nodal and ventricular tachycardias; atrial flutter and fibrillation; ventricular fibrillation; when other drugs cannot be used. Cordarone X Intravenous can be used where a rapid response is required or where oral administration is not possible. 4.2 Posology and method of administration Cordarone X Intravenous should only be used when facilities exist for cardiac monitoring, defibrillation, and cardiac pacing. Cordarone X Intravenous may be used prior to DC cardioversion. The standard recommended dose is 5mg/kg bodyweight given by intravenous infusion over a period of 20 minutes to 2 hours. This should be administered as a dilute solution in 250ml 5% dextrose. This may be followed by repeat infusion up to 1200mg (approximately 15mg/kg bodyweight) in up to 500ml 5% dextrose per 24 hours, the rate of infusion being adjusted on the basis of clinical response _(see section _ _4.4)._ In extreme clinical emergency the drug may, at the discretion of the clinician, be given as a slow injection of 150-300mg in 10-20ml 5% dextrose over a minimum of 3 minutes. This should not be repeated for at least 15 minutes. Patients treated in this way with Cordarone X Intravenous must be closely monitored, e.g. in an intensive care unit _(see section 4.4)._ _CHANGEO Կարդացեք ամբողջական փաստաթուղթը